Stay updated on Pembrolizumab in Endometrial Cancer Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab in Endometrial Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab in Endometrial Cancer Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    Change Detected
    Summary
    Access to the study record now displays a 403 Forbidden page instead of the study content. This blocks core study details and related information from being visible on the page.
    Difference
    18%
    Check dated 2026-09-23T01:14:59.000Z thumbnail image
  3. Check
    15 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.7.0, replacing the previous v3.6.6. This reflects a backend or template update and does not alter the study content shown to users.
    Difference
    0.1%
    Check dated 2026-09-16T00:31:54.000Z thumbnail image
  4. Check
    29 days ago
    Change Detected
    Summary
    The page's revision version was updated from v3.6.5 to v3.6.6, indicating an editorial update to the page. This change does not alter the study data or how the page presents information.
    Difference
    0.1%
    Check dated 2026-09-01T20:55:41.000Z thumbnail image
  5. Check
    50 days ago
    Change Detected
    Summary
    Revision: v3.6.5 has been added, replacing Revision: v3.6.4, signaling a software version update. This change appears to be an backend/UI update rather than a modification to the study details or page content.
    Difference
    0.1%
    Check dated 2026-08-11T17:25:39.000Z thumbnail image
  6. Check
    65 days ago
    Change Detected
    Summary
    The page footer revision tag was updated from v3.6.3 to v3.6.4. This indicates a small maintenance release and does not change page content or functionality.
    Difference
    0.1%
    Check dated 2026-07-28T05:34:36.000Z thumbnail image
  7. Check
    86 days ago
    Change Detected
    Summary
    The page's revision tag was updated from v3.6.2 to v3.6.3. This indicates a minor platform update and does not affect study content or presented results.
    Difference
    0.1%
    Check dated 2026-07-06T16:37:53.000Z thumbnail image

Stay in the know with updates to Pembrolizumab in Endometrial Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Endometrial Cancer Clinical Trial page.